Sidney Schnoll, MD, PhD

Vice President, Pharmaceutical Risk Management

Evaluating the benefit-risk balance of CNS-active drugs in postmarketing studies and REMS

Expertise

With a career that has spanned patient care, academia and industry, Sidney (Sid) is an internationally recognized authority on substance use disorders, pain management, and managing the risk of CNS-active drugs through postmarketing risk management. Sid counsels clients on:

  • Regulatory and scientific strategy, and FDA engagement
  • Premarketing risk assessment
  • Postmarketing risk management planning, implementation, and surveillance reporting
  • Risk Evaluation and Mitigation Strategies

Experience

Sid has served on the FDA Drug Abuse Advisory Committee, NIH study sections, and the board of the College on Problems of Drug Dependence.

He was a member of the team that developed the Tramadol Independent Steering Committee, establishing one of the first extensive postmarketing studies of a CNS-active drug. At Purdue Pharma L.P., he developed the RADARS® System to study the abuse and diversion of prescription opioids, and continues today as a member of the RADARS® System Scientific Advisory Board and Industry Advisory Board.

Earlier, he was the Career Teacher in addictions at the University of Pennsylvania; Medical Director at the Eagleville Hospital and Rehabilitation Center; and Associate Professor of Psychiatry and Pharmacology and Director of Chemical Dependence Programs at Northwestern University Medical School (now Feinberg School of Medicine).

At the Medical College of Virginia, Virginia Commonwealth University (now VCU School of Medicine) he chaired the school’s Division of Substance Abuse Medicine, where he held faculty positions in internal medicine, psychiatry, psychology and pharmacology/toxicology.

A fellow of both the College on Problems of Drug Dependence and the American Society of Addiction Medicine, Sid has to his credit more than 150 research papers, book chapters, and educational works in the areas of substance abuse, addiction, and pain treatment.

Education

  • PhD, Pharmacology, Thomas Jefferson University
  • MD, New Jersey College of Medicine and Dentistry (now Rutgers New Jersey Medical School)
  • BS, Union College

Back to our team